Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Ready Capital Corporation issued an earnings release on August 6, 2026 announcing financial results for the quarter ended June 30, 2026, with the press release attached as Exhibit 99.1. The disclosure includes GAAP loss per common share of $(0.63), distributable loss per common share of $(0.47), balance sheet metrics, portfolio information, and detailed consolidated financial statements. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Ellington Financial Inc. issued a press release on August 6, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing net income of $54.4 million ($0.43 per share), adjusted distributable earnings of $75.5 million ($0.60 per share), and book value per share of $13.61.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release for Q2 2026 (three months ended June 30, 2026) filed under Item 2.02. The press release discloses comprehensive financial results including revenue of $652.5 million, net loss of $28.4 million, Adjusted EBITDA of $28.1 million, and updated 2026 guidance raising revenue to $2.6–$2.7 billion and tightening Adjusted EBITDA to $120–$135 million. The filing includes consolidated statements of operations and balance sheets, making this a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
Cable One issued a press release on August 6, 2026 disclosing its financial and operating results for the second quarter ended June 30, 2026. The filing includes detailed revenue, net loss, EBITDA, and cash flow metrics for Q2 2026 versus Q2 2025, along with a summary of key operational and financial developments. This is a standard quarterly earnings release disclosure under Item 2.02, with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Roivant issued a press release on August 6, 2026, announcing its financial results for the fiscal quarter ended June 30, 2026, disclosing consolidated financial statements including revenue, operating expenses, net loss of $290.6 million, and cash position of $3.9 billion. The filing explicitly states this is Item 2.02 Results of Operations and Financial Condition with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-06
Item 2.01
Health Catalyst completed the divestiture of VitalWare, LLC to Med-Metrix, LLC on July 31, 2026, for a base purchase price of $147 million. The company used the proceeds to prepay and terminate its credit facility, representing a significant strategic transaction affecting the company's asset base and financial position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Health Catalyst issued a Q2 2026 earnings release on August 6, 2026 disclosing financial results for the quarter ended June 30, 2026, including revenue of $70.5M, net loss of $40.5M, and Adjusted EBITDA of $9.9M, along with forward guidance for Q3 and full-year 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Planet Fitness issued a press release on August 6, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing total revenue of $365.2 million (up 7.1%), net income of $67.1 million ($0.87 per diluted share), and Adjusted EBITDA of $152.8 million. The Item 2.02 disclosure explicitly states the press release is being furnished as Exhibit 99.1 and incorporated by reference, which is the standard format for earnings releases under Item 2.02 of Form 8-K.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Peloton disclosed its quarterly and full-year financial results for the period ended June 30, 2026 via a press release furnished as Exhibit 99.1. The disclosure includes Q4 and FY2026 revenue ($608M and $2.446B respectively), net income ($62M and $63M), Adjusted EBITDA ($142M and $468M), and forward guidance for Q1 and FY2027. This is a standard earnings release under Item 2.02, material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Voyager's second quarter 2026 financial results, including collaboration revenue ($3.2M), R&D expenses ($22.0M), G&A expenses ($7.5M), net loss ($24.5M), and cash position ($148.8M with runway into 2028). The press release is furnished as Exhibit 99.1 and Item 2.02 explicitly states the company "announced second quarter 2026 financial results and corporate updates." The disclosure includes both financial statements (consolidated balance sheet and statement of operations) and material operational milestones (VY7523 and VY1706 clinical data expected Q4 2026).
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
vTv Therapeutics issued a press release on August 6, 2026, announcing financial results for the fiscal period ended June 30, 2026, including condensed consolidated balance sheets and statements of operations showing Q2 2026 results (net loss of $13.1 million, cash position of $86.6 million) and six-month results. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial condition and cash runway through anticipated clinical trial data readout.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
CPI Card Group Inc. issued a press release on August 6, 2026, announcing Q2 2026 financial results with revenue of $149.2 million (15% increase), net income of $2.0 million (294% increase), and Adjusted EBITDA of $24.1 million (7% increase), along with raised 2026 guidance for revenue growth and Free Cash Flow.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
WillScot issued a press release on August 6, 2026 announcing second quarter 2026 financial results, including revenue of $612 million, net income of $47 million, and Adjusted EBITDA of $228 million, along with a raised full-year 2026 outlook. This is a standard quarterly earnings release disclosure under Item 2.02, with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Atlassian disclosed quarterly and fiscal year 2026 financial results, reporting Q4 revenue of $1,766 million (up 28% YoY), cloud revenue of $1,213 million (up 31% YoY), subscription ARR of $6,606 million (up 23% YoY), and a return to GAAP profitability with 12% operating margin.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Priority Technology Holdings issued a press release on August 6, 2026 announcing its second quarter 2026 financial results, including revenue of $262.3 million (9.4% YoY growth), net income of $9.9 million, diluted EPS of $0.12, and adjusted EBITDA of $59.4 million, along with full-year 2026 guidance. The disclosure includes a scheduled earnings conference call and webcast for the same date.
View raw filing on EDGAR →
6-K
Periodic Interim
confidence 95%
filed 2026-08-06
This is WPP plc's H1 2026 interim financial results report, dated 6 August 2026. The document presents unaudited interim financial statements with revenue, operating profit, earnings per share, cash flow, and balance sheet metrics for the first half of 2026, along with management commentary on business performance and forward guidance. This is a periodic interim financial report (the foreign-issuer equivalent of a 10-Q), not a discrete event or earnings press release.
View raw filing on EDGAR →
6-K
Periodic Annual
confidence 95%
filed 2026-08-06
This is Diageo's preliminary results announcement for the fiscal year ended 30 June 2026, presenting full-year financial statements including net sales ($19.6B), operating profit ($3.2B), net profit ($1.96B), and EPS (78.1c). The document is explicitly titled "DIAGEO PRELIMINARY RESULTS 2026" and covers the complete fiscal year, making it a periodic annual financial report rather than a discrete event or earnings press release. The 6-K furnishes the body of the report itself (no separate exhibits), which is the foreign-issuer equivalent of a 10-K/Form 20-F annual report.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-06
This 6-K announces Diageo's Capital Markets Day and provides forward-looking strategic guidance and operational restructuring plans. The disclosure includes material operational initiatives: a ~$1 billion cost-savings program over three years (operating framework redesign of ~$850 million and supply chain savings of ~$150 million), fiscal 27 guidance (broadly flat organic net sales growth, low-to-mid-single-digit organic operating profit growth), and medium-term CAGR guidance through fiscal 29. While the announcement contains financial projections and cost-saving targets, it is fundamentally a strategic business announcement tied to an investor event rather than a discrete financial event (earnings release), M&A activity, or other named category. The operational restructuring and strategic repositioning would materially affect a reasonable investor's assessment of the company's direction and performance trajectory.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 85%
filed 2026-08-06
HSBC announced an increase in the maximum tender amount for its debt tender offers from $5.0 billion to $6.75 billion, and increased the May 2028 Notes sub-cap from $750 million to $1.0 billion. The company is undertaking these offers to "proactively manage the Company's outstanding debt portfolio" and expects to finance the repurchases with proceeds from a concurrent new debt issuance ($2.5B + $3.25B + $1.0B = $6.75B in new notes priced on August 5, 2026). This is a material debt management activity involving both new debt issuance and debt repurchase/retirement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Airship AI Holdings issued a press release announcing its financial and operational results for Q2 2026 (quarter ended June 30, 2026), reporting net revenues of $4.12 million (92% YoY increase), gross profit of $3.09 million (102% YoY increase), and a net loss of $2.4 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-08-06
Item 8.01
The filing discloses FHLBNY's "Second Quarter 2026 Operating Highlights," including $153.3 million in net income for Q2, $128 billion in funding to members (up $35 billion from year-end 2025), and $27.5 million allocated to affordable housing initiatives. While presented as a President's Report rather than a formal earnings press release, the core disclosure is quarterly financial results and operational metrics material to shareholders' assessment of the institution's performance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-06
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of New York. Schedule A details two specific debt issuances: a $10 million fixed-rate bond maturing in 2031 and a $1 billion variable-rate discount note maturing in 2026. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations created by the registrant in the capital markets.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states "Cronos Group Inc. (the 'Company') issued a press release announcing its financial results for its second quarter ended June 30, 2026," with the press release attached as Exhibit 99.1. The exhibit contains consolidated financial results showing net revenue of $53.0 million (up 58% YoY), gross profit of $28.5 million (up 96% YoY), and Adjusted EBITDA of $13.1 million (up 675% YoY), along with detailed business performance metrics and brand updates.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Hertz Global Holdings issued a press release on August 6, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $2.4 billion (up 10% YoY), GAAP net income of $64 million, and Adjusted Corporate EBITDA of $81 million. This is a standard quarterly earnings release filed under Item 2.02 with the press release attached as Exhibit 99.1, which is the typical format for earnings disclosures and material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release for Q2 2026 (period ending June 30, 2026) disclosed via press release on August 6, 2026. The filing reports comprehensive financial results including GMV of $1.3 billion (up 37.9% YoY), Total Revenue of $149.7 million (up 51.7% YoY), Net Income of $40.8 million (up 47.7% YoY), and updated FY2026 guidance raising Adjusted Net Income to $185.0 million. The disclosure is material to investors as it presents quarterly operating results, key metrics, and forward guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
US Foods disclosed its financial results for the fiscal second quarter ended June 27, 2026 via a press release attached as Exhibit 99.1. The disclosure includes key metrics such as net sales growth of 4.5% to $10.5 billion, net income growth of 22.8% to $275 million, diluted EPS of $1.24, and adjusted EBITDA growth of 10.2% to a record $604 million. This is a standard quarterly earnings release with comprehensive financial results and forward guidance, clearly falling under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Immunocore's Q2 2026 financial results, including net product revenues of $115.9 million (18% YoY growth), R&D and SG&A expenses, net loss of $0.8 million, and cash position of $880.2 million as of June 30, 2026. The press release is furnished as Exhibit 99.1 and Item 2.02 explicitly states the Company "issued a press release announcing its financial results for the second quarter ended June 30, 2026." This is a material disclosure affecting investor assessment of the registrant's financial performance and operational progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
The Trade Desk issued a press release on August 6, 2026 announcing its financial results for the quarter ended June 30, 2026, with detailed GAAP and non-GAAP financial metrics (revenue of $715 million, net income of $64 million, diluted EPS of $0.14), business highlights, and forward guidance for Q3 2026. This is a standard quarterly earnings disclosure furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Acushnet Holdings Corp. issued a press release on August 6, 2026 announcing quarterly and year-to-date financial results for the period ended June 30, 2026. The disclosure includes detailed net sales figures ($820.0 million for Q2, up 13.8% YoY), net income ($124.8 million, up 65.1% YoY), and Adjusted EBITDA ($208.6 million, up 45.8% YoY), along with updated full-year 2026 guidance. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
This is a clear earnings release for Q2 2026 (three and six month periods ended June 30, 2026) issued on August 5, 2026. The Item 2.02 disclosure explicitly states the company "issued a press release...announcing its financial results for the three and six month periods ended June 30, 2026," with the full earnings release attached as Exhibit 99.1. The release includes detailed financial results (net interest income, provision for credit losses, net loss, balance sheet metrics, book value per share) and is material to investors assessing the registrant's financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
Unusual Machines, Inc. disclosed Q2 2026 financial results, including revenue of $16.7 million (687% YoY growth), gross margin of 34.7%, operating loss of $7.8 million, and net loss of $7.8 million ($0.16 per share), along with a shareholder letter from CEO Allan Evans and announcement of a conference call to discuss results.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 90%
filed 2026-08-06
Item 3.02
On July 31, 2026, Valion Bio entered into a Securities Purchase Agreement with Statera and Avenue Venture Opportunities Fund, issuing 1,287.8685 shares of Series A Preferred Stock as consideration for a Milestone Payment. The shares are unregistered, restricted securities issued under Section 4(a)(2) and Regulation D exemptions to accredited investors, materially diluting existing shareholder ownership.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Applied Optoelectronics issued a press release on August 6, 2026 disclosing financial results for Q2 2026 ended June 30, 2026. The disclosure includes GAAP revenue of $191.9 million (up 86% YoY), gross margin, net loss, and non-GAAP profitability metrics, along with Q3 2026 guidance. This is a standard earnings release attached as Exhibit 99.1 under Item 2.02, and the results are material to investors as they show record revenue for the fifth consecutive quarter and a return to non-GAAP profitability.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a straightforward earnings release disclosing Q2 2026 financial results for Establishment Labs Holdings Inc. The filing explicitly states in Item 2.02 that the company "issued a press release announcing the Company's financial results for the three and six months ended June 30, 2026 and recent corporate highlights," with the press release furnished as Exhibit 99.1. The disclosure includes revenue of $67.5 million (up 31.7% YoY), gross margin of 70.6%, and raised full-year guidance to $269-271 million, all material metrics for investor assessment.
View raw filing on EDGAR →
8-K
Earnings release
confidence 94%
filed 2026-08-06
Item 2.02
Praxis Precision Medicines reported Q2 2026 financial results, including R&D expenses of $69.4M, G&A expenses of $27.5M, a net loss of $83.7M, and a cash position of $1.4B as of June 30, 2026. The disclosure includes operational highlights and anticipated milestones for the company's drug development programs, providing investors with visibility into the company's financial performance and cash runway into 2028.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Kinetik issued a press release on August 5, 2026 announcing financial and operating results for the fiscal quarter ended June 30, 2026, disclosing net income of $123.1 million and $118.0 million for the three and six months ended June 30, 2026, respectively, along with Adjusted EBITDA, Distributable Cash Flow, and Free Cash Flow metrics. The company also raised full year 2026 Adjusted EBITDA guidance to $1.04–$1.1 billion. This is a standard quarterly earnings release with material financial results and forward guidance that would affect a reasonable investor's assessment of the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Once Upon a Farm issued a press release on August 6, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing net sales of $85.4 million (42.3% YoY growth), net loss of $5.0 million, and raising full-year 2026 guidance for both net sales ($327–$335 million) and Adjusted EBITDA ($3–$4.5 million). This is a classic earnings release disclosure under Item 2.02, furnished with the press release as Exhibit 99.1 and accompanied by detailed financial statements and management commentary.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
The filing discloses quarterly financial results for Q2 2026 via a press release attached as Exhibit 99.1. The press release reports net revenue of $17.2 million (56% growth), gross margin of 78.3%, and raises full-year 2026 guidance to $67–69 million. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and growth trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) filed on August 6, 2026. The Item 2.02 disclosure explicitly states "Optimum Communications, Inc. announced its financial results for the quarter ended June 30, 2026" with a press release attached as Exhibit 99.1. The exhibit contains comprehensive financial results including revenue ($2.02 billion), net loss ($291.8 million), Adjusted EBITDA ($785.7 million), and detailed operational metrics. This is a material disclosure affecting investor assessment of the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Funko disclosed consolidated financial results for Q2 2026 (three and six months ended June 30, 2026) via press release, reporting net sales of $207.7 million (7% growth), record gross margin of 56.6%, net income of $15.4 million ($0.27 per diluted share), and raising full-year Adjusted EBITDA guidance to $100M–$110M.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Core Natural Resources issued a press release on August 6, 2026 announcing its second quarter 2026 financial results, disclosing net income of $126.5 million ($2.51 per diluted share), adjusted EBITDA of $323.6 million, and free cash flow of $148 million, along with comprehensive operational metrics, segment performance, and forward guidance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-06
The 6-K body explicitly states it "contains: Exhibit 1: Loma Negra Earnings Release 2Q26," indicating disclosure of second-quarter 2026 financial results. Earnings releases are material events that affect investor assessment of the registrant's financial performance and are commonly furnished as exhibits to Form 6-K by foreign private issuers.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Burford Capital issued a press release and detailed presentation on August 6, 2026, announcing its unaudited financial results for the three and six months ended June 30, 2026 (2Q26 and YTD26). The disclosure includes quarterly financial results, cash position ($733 million), and portfolio performance commentary from the CEO. This is a standard earnings release disclosure under Item 2.02, with exhibits 99.1 and 99.2 containing the press release and presentation respectively.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Denali Therapeutics' second quarter 2026 financial results. The Item 2.02 filing explicitly states "On August 6, 2026, Denali Therapeutics Inc. (the 'Company') issued a press release announcing its financial results for the second quarter ended June 30, 2026." The press release (Exhibit 99.1) reports Q2 2026 net product revenue of $3.6 million, R&D expenses of $97.0 million, SG&A expenses of $36.3 million, and a net loss of $127.6 million, along with cash position and business highlights. This is a material disclosure affecting investor assessment of the company's financial condition and operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
Zentalis Pharmaceuticals reported second quarter 2026 financial results and business updates, including cash position of $174.6 million, R&D expenses of $35.2 million, and G&A expenses of $9.2 million, along with material clinical milestones including DENALI enrollment completion, FDA Type D meeting alignment, and ASPENOVA Phase 3 first patient dosed.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-06
Item 2.02
Frontdoor issued a press release on August 6, 2026, announcing its financial results for the fiscal quarter ended June 30, 2026. The disclosure includes detailed quarterly financial metrics (revenue of $645 million, net income of $125 million, EPS of $1.76), year-to-date performance, and raised full-year 2026 guidance for revenue and Adjusted EBITDA. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
i3 Verticals issued a press release on August 6, 2026, announcing financial results for the three and nine months ended June 30, 2026, including revenue of $53.1 million (up 2.2% YoY), net income from continuing operations of $5.9 million, adjusted EBITDA of $13.3 million, diluted EPS, and revised fiscal 2026 guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Arlo Technologies issued a press release on August 6, 2026 announcing its financial results for the second quarter ended June 28, 2026, disclosing record total revenue of $156 million (up 21% YoY), record adjusted EBITDA of $31 million, and GAAP EPS of $0.03. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Nuveen Churchill Direct Lending Corp. disclosed its Q2 2026 financial results for the quarter ended June 30, 2026, reporting net investment income of $0.41 per share, net realized and unrealized losses, and NAV per share of $17.19. The earnings release was issued on August 6, 2026 and included consolidated financial statements and operational highlights.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
BlackSky issued a press release on August 6, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing total revenue of $33.3 million (up 50% YoY), record space-based intelligence revenue of $25 million, net loss of $20.8 million, and Adjusted EBITDA of $4.7 million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →